Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

reported in clinical trials: a joint position statement of the American Association and the Europian Association for the Study of Diabetes. The International Hypoglycaemia Study Group recom-mends that the frequency of detection of a glucose concentration <3.0 mmol/l (<54 mg/dl), which it considers to be clinically significant biochemical hypoglycaemia, be included in reports of clinical trials of glucose-lowering drugs evaluated for the treatment of diabetes mellitus. The glycaemic thresholds symptoms of hypoglycaemia and for glucose counterregulatory responses to hypoglycaemia, at glycaemic glucose iatrogenic Glycaemic